These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9063299)

  • 1. Determinants of change in Medicaid pharmaceutical cost sharing: does evidence affect policy?
    Soumerai SB; Ross-Degnan D; Fortess EE; Walser BL
    Milbank Q; 1997; 75(1):11-34. PubMed ID: 9063299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Health Outcomes and Prescription Drug Copayments in Medicaid.
    Kostova D; Fox J
    Med Care; 2017 May; 55(5):520-527. PubMed ID: 28234755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid prescription drug coverage: state efforts to control costs.
    Gencarelli DM
    NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Changes or Big Ones? The Case of Limits on Prescription Drug Copayments in California.
    Pyenson B; Dieguez G; Simon K; Bochner A
    Manag Care; 2018 Jul; 27(7):27-29. PubMed ID: 29989898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicaid policies for HIV-related prescription drugs.
    Buchanan RJ; Smith SR
    Health Care Financ Rev; 1994; 15(3):43-61. PubMed ID: 10137797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical analysis of studies of state drug reimbursement policies: research in need of discipline.
    Soumerai SB; Ross-Degnan D; Fortess EE; Abelson J
    Milbank Q; 1993; 71(2):217-52. PubMed ID: 8510601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.
    Soumerai SB; Avorn J; Ross-Degnan D; Gortmaker S
    N Engl J Med; 1987 Aug; 317(9):550-6. PubMed ID: 3302713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-eligible policy could fall short.
    Gold MF
    Provider; 1998 Apr; 24(4):27-8. PubMed ID: 10178105
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription drug access: not just a Medicare problem.
    Cunningham PJ
    Issue Brief Cent Stud Health Syst Change; 2002 Apr; (51):1-4. PubMed ID: 11977267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who bears the burden of Medicaid drug copayment policies?
    Stuart B; Zacker C
    Health Aff (Millwood); 1999; 18(2):201-12. PubMed ID: 10091449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicaid prescription limits: policy trends and comparative impact on utilization.
    Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
    BMC Health Serv Res; 2016 Jan; 16():15. PubMed ID: 26772962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment.
    Domino ME; Martin BC; Wiley-Exley E; Richards S; Henson A; Carey TS; Sleath B
    Health Serv Res; 2011 Jun; 46(3):900-19. PubMed ID: 21306363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The international generalisability of evidence for health policy: A cross country comparison of medication adherence following policy change.
    Sinnott SJ; Whelton H; Franklin JM; Polinski JM
    Health Policy; 2017 Jan; 121(1):27-34. PubMed ID: 27916432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a Medicaid drug copayment program on the utilization and cost of prescription services.
    Nelson AA; Reeder CE; Dickson WM
    Med Care; 1984 Aug; 22(8):724-36. PubMed ID: 6433121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumer Cost-Sharing in Marketplace vs. Employer Health Insurance Plans, 2015.
    Gabel J; Whitmore H; Green M; Stromberg S; Oran R
    Issue Brief (Commonw Fund); 2015 Dec; 38():1-11. PubMed ID: 26761957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plans continue to raise copayments.
    Manag Care; 2005 Sep; 14(9):59. PubMed ID: 16238260
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicare: looking for pareto optimal changes.
    Christensen S
    Inquiry; 1992; 29(4):426-39. PubMed ID: 1473866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.